Cargando…

Paradigm shift of drug information centers during the COVID-19 pandemic

The novel coronavirus disease 2019 (COVID-19) pandemic is a major global threat affecting millions of lives throughout the world physically and psychologically. With the asymptomatic presentation of COVID-19 in many patients and the similarity of its symptoms with the common cold and influenza, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Khatiwada, Asmita Priyadarshini, Shakya, Sujyoti, Shrestha, Sunil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7370873/
https://www.ncbi.nlm.nih.gov/pubmed/32837192
http://dx.doi.org/10.1007/s40267-020-00757-3
_version_ 1783561049764528128
author Khatiwada, Asmita Priyadarshini
Shakya, Sujyoti
Shrestha, Sunil
author_facet Khatiwada, Asmita Priyadarshini
Shakya, Sujyoti
Shrestha, Sunil
author_sort Khatiwada, Asmita Priyadarshini
collection PubMed
description The novel coronavirus disease 2019 (COVID-19) pandemic is a major global threat affecting millions of lives throughout the world physically and psychologically. With the asymptomatic presentation of COVID-19 in many patients and the similarity of its symptoms with the common cold and influenza, the need for accurate information on the disease is very important for its identification and proper management. Accurate information on the disease, its prevention and treatment can be disseminated through drug information centers (DICs). DICs are usually staffed by pharmacists and/or clinical pharmacists/pharmacologists. DICs are a reliable source of current and unbiased information on COVID-19 and its associated complications, including management options for healthcare professionals and the public. In addition to health and drug information, pharmacists working in the DICs can be involved in the management of the patients’ health by providing information on home care and safety, medication management of patients with chronic comorbid illnesses, and psychological advice. This article explores the possible additional roles DICs can play, besides providing drug information within the hospital or in the community.
format Online
Article
Text
id pubmed-7370873
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-73708732020-07-20 Paradigm shift of drug information centers during the COVID-19 pandemic Khatiwada, Asmita Priyadarshini Shakya, Sujyoti Shrestha, Sunil Drugs Ther Perspect Current Opinion The novel coronavirus disease 2019 (COVID-19) pandemic is a major global threat affecting millions of lives throughout the world physically and psychologically. With the asymptomatic presentation of COVID-19 in many patients and the similarity of its symptoms with the common cold and influenza, the need for accurate information on the disease is very important for its identification and proper management. Accurate information on the disease, its prevention and treatment can be disseminated through drug information centers (DICs). DICs are usually staffed by pharmacists and/or clinical pharmacists/pharmacologists. DICs are a reliable source of current and unbiased information on COVID-19 and its associated complications, including management options for healthcare professionals and the public. In addition to health and drug information, pharmacists working in the DICs can be involved in the management of the patients’ health by providing information on home care and safety, medication management of patients with chronic comorbid illnesses, and psychological advice. This article explores the possible additional roles DICs can play, besides providing drug information within the hospital or in the community. Springer International Publishing 2020-07-20 2020 /pmc/articles/PMC7370873/ /pubmed/32837192 http://dx.doi.org/10.1007/s40267-020-00757-3 Text en © Springer Nature Switzerland AG 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Current Opinion
Khatiwada, Asmita Priyadarshini
Shakya, Sujyoti
Shrestha, Sunil
Paradigm shift of drug information centers during the COVID-19 pandemic
title Paradigm shift of drug information centers during the COVID-19 pandemic
title_full Paradigm shift of drug information centers during the COVID-19 pandemic
title_fullStr Paradigm shift of drug information centers during the COVID-19 pandemic
title_full_unstemmed Paradigm shift of drug information centers during the COVID-19 pandemic
title_short Paradigm shift of drug information centers during the COVID-19 pandemic
title_sort paradigm shift of drug information centers during the covid-19 pandemic
topic Current Opinion
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7370873/
https://www.ncbi.nlm.nih.gov/pubmed/32837192
http://dx.doi.org/10.1007/s40267-020-00757-3
work_keys_str_mv AT khatiwadaasmitapriyadarshini paradigmshiftofdruginformationcentersduringthecovid19pandemic
AT shakyasujyoti paradigmshiftofdruginformationcentersduringthecovid19pandemic
AT shresthasunil paradigmshiftofdruginformationcentersduringthecovid19pandemic